Literature DB >> 22403803

AGR2 is induced in asthma and promotes allergen-induced mucin overproduction.

Bradley W Schroeder1, Catherine Verhaeghe, Sung-Woo Park, Louis T Nguyenvu, Xiaozhu Huang, Guohua Zhen, David J Erle.   

Abstract

Mucins are gel-forming proteins that are responsible for the characteristic viscoelastic properties of mucus. Mucin overproduction is a hallmark of asthma, but the cellular requirements for airway mucin production are poorly understood. The endoplasmic reticulum (ER) protein anterior gradient homolog 2 (AGR2) is required for production of the intestinal mucin MUC2, but its role in the production of the airway mucins MUC5AC and MUC5B is not established. Microarray data were analyzed to examine the relationship between AGR2 and MUC5AC expression in asthma. Immunofluorescence was used to localize AGR2 in airway cells. Coimmunoprecipitation was used to identify AGR2-immature MUC5AC complexes. Agr2(-/-) mice were used to determine the role of AGR2 in allergic airway disease. AGR2 localized to the ER of MUC5AC- and MUC5B-producing airway cells and formed a complex with immature MUC5AC. AGR2 expression increased together with MUC5AC expression in airway epithelium from "Th2-high" asthmatics. Allergen-challenged Agr2(-/-) mice had greater than 50% reductions in MUC5AC and MUC5B proteins compared with allergen-challenged wild-type mice. Impaired mucin production in Agr2(-/-) mice was accompanied by an increase in the proportion of mucins contained within the ER and by evidence of ER stress in airway epithelium. This study shows that AGR2 increases with mucin overproduction in individuals with asthma and in mouse models of allergic airway disease. AGR2 interacts with immature mucin in the ER and loss of AGR2 impairs allergen-induced MUC5AC and MUC5B overproduction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403803      PMCID: PMC3423459          DOI: 10.1165/rcmb.2011-0421OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  41 in total

Review 1.  Respiratory tract mucin genes and mucin glycoproteins in health and disease.

Authors:  Mary Callaghan Rose; Judith A Voynow
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

2.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

3.  Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis.

Authors:  J Bara; R Gautier; P Mouradian; C Decaens; N Daher
Journal:  Int J Cancer       Date:  1991-01-21       Impact factor: 7.396

4.  Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the Golgi apparatus.

Authors:  N Asker; M A Axelsson; S O Olofsson; G C Hansson
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

5.  Molecular cloning of human gastric mucin MUC5AC reveals conserved cysteine-rich D-domains and a putative leucine zipper motif.

Authors:  J H van de Bovenkamp; C M Hau; G J Strous; H A Büller; J Dekker; A W Einerhand
Journal:  Biochem Biophys Res Commun       Date:  1998-04-28       Impact factor: 3.575

6.  Specificity in substrate binding by protein folding catalysts: tyrosine and tryptophan residues are the recognition motifs for the binding of peptides to the pancreas-specific protein disulfide isomerase PDIp.

Authors:  L W Ruddock; R B Freedman; P Klappa
Journal:  Protein Sci       Date:  2000-04       Impact factor: 6.725

7.  Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression.

Authors:  C L Ordoñez; R Khashayar; H H Wong; R Ferrando; R Wu; D M Hyde; J A Hotchkiss; Y Zhang; A Novikov; G Dolganov; J V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

8.  Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae.

Authors:  J Bara; R Gautier; N Daher; H Zaghouani; C Decaens
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

Review 9.  Airway mucus hypersecretion in asthma: an undervalued pathology?

Authors:  Duncan F Rogers
Journal:  Curr Opin Pharmacol       Date:  2004-06       Impact factor: 5.547

10.  Human MUC5AC mucin dimerizes in the rough endoplasmic reticulum, similarly to the MUC2 mucin.

Authors:  N Asker; M A Axelsson; S O Olofsson; G C Hansson
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

View more
  43 in total

1.  Intercellular Communication between Airway Epithelial Cells Is Mediated by Exosome-Like Vesicles.

Authors:  Richa Gupta; Giorgia Radicioni; Sabri Abdelwahab; Hong Dang; Jerome Carpenter; Michael Chua; Piotr A Mieczkowski; John T Sheridan; Scott H Randell; Mehmet Kesimer
Journal:  Am J Respir Cell Mol Biol       Date:  2019-02       Impact factor: 6.914

Review 2.  The UPR and lung disease.

Authors:  Fabiola Osorio; Bart Lambrecht; Sophie Janssens
Journal:  Semin Immunopathol       Date:  2013-03-28       Impact factor: 9.623

3.  XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia.

Authors:  Gang Chen; Carla M P Ribeiro; Ling Sun; Kenichi Okuda; Takafumi Kato; Rodney C Gilmore; Mary B Martino; Hong Dang; Aiman Abzhanova; Jennifer M Lin; Emily A Hull-Ryde; Allison S Volmer; Scott H Randell; Alessandra Livraghi-Butrico; Yingfeng Deng; Philipp E Scherer; Barry R Stripp; Wanda K O'Neal; Richard C Boucher
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

Review 4.  Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions.

Authors:  William J Janssen; Adrianne L Stefanski; Bruce S Bochner; Christopher M Evans
Journal:  Eur Respir J       Date:  2016-09-01       Impact factor: 16.671

5.  The Endoplasmic Reticulum Resident Protein AGR3. Required for Regulation of Ciliary Beat Frequency in the Airway.

Authors:  Luke R Bonser; Bradley W Schroeder; Lisa A Ostrin; Nathalie Baumlin; Jean L Olson; Matthias Salathe; David J Erle
Journal:  Am J Respir Cell Mol Biol       Date:  2015-10       Impact factor: 6.914

6.  Protein disulfide isomerase-endoplasmic reticulum resident protein 57 regulates allergen-induced airways inflammation, fibrosis, and hyperresponsiveness.

Authors:  Sidra M Hoffman; David G Chapman; Karolyn G Lahue; Jonathon M Cahoon; Gurkiranjit K Rattu; Nirav Daphtary; Minara Aliyeva; Karen A Fortner; Serpil C Erzurum; Suzy A A Comhair; Prescott G Woodruff; Nirav Bhakta; Anne E Dixon; Charles G Irvin; Yvonne M W Janssen-Heininger; Matthew E Poynter; Vikas Anathy
Journal:  J Allergy Clin Immunol       Date:  2015-10-04       Impact factor: 10.793

Review 7.  Update on the role of endoplasmic reticulum stress in asthma.

Authors:  Kang Miao; Lei Zhang; Ting Pan; Yi Wang
Journal:  Am J Transl Res       Date:  2020-04-15       Impact factor: 4.060

8.  Effect of a chemical chaperone, tauroursodeoxycholic acid, on HDM-induced allergic airway disease.

Authors:  Jalahalli M Siddesha; Emily M Nakada; Bethany R Mihavics; Sidra M Hoffman; Gurkiranjit K Rattu; Nicolas Chamberlain; Jonathon M Cahoon; Karolyn G Lahue; Nirav Daphtary; Minara Aliyeva; David G Chapman; Dhimant H Desai; Matthew E Poynter; Vikas Anathy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-06       Impact factor: 5.464

Review 9.  IL-4 and IL-13 signaling in allergic airway disease.

Authors:  Naina Gour; Marsha Wills-Karp
Journal:  Cytokine       Date:  2015-06-09       Impact factor: 3.861

10.  IL1RL1 asthma risk variants regulate airway type 2 inflammation.

Authors:  Erin D Gordon; Joe Palandra; Agata Wesolowska-Andersen; Lando Ringel; Cydney L Rios; Marrah E Lachowicz-Scroggins; Louis Z Sharp; Jamie L Everman; Hannah J MacLeod; Jae W Lee; Robert J Mason; Michael A Matthay; Richard T Sheldon; Michael C Peters; Karl H Nocka; John V Fahy; Max A Seibold
Journal:  JCI Insight       Date:  2016-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.